Why is Marksans Pharma falling/rising?

As of 10-Oct, Marksans Pharma Ltd is experiencing a price increase, currently at Rs 181.75, reflecting a rise of Rs 12.4 or 7.32%. The stock has shown strong performance today, outperforming its sector by 6.09% and has gained 10.65% over the last two days. It opened with a gain of 2.6% and reached an intraday high of Rs 186.85. The stock has also seen a significant increase in delivery volume, rising by 171.94% against the 5-day average, indicating rising investor participation. However, despite these positive short-term movements, the company has faced challenges in the long term, with a decline in operating profit and a negative return of -36.65% over the past year.
In the broader market context, Marksans Pharma's short-term return of +9.03% over the past week significantly outpaces the Sensex's return of +1.59%, suggesting that the stock is gaining traction relative to the market. However, it is important to note that the stock has underperformed over the longer term, with a year-to-date return of -38.65% compared to the Sensex's +5.58%. This disparity highlights the stock's volatility and the challenges it faces, including poor long-term growth and high valuation metrics, which may temper investor enthusiasm despite recent gains.